Internal Medicine · Clairton, PA
NPI
1487616132
Since 2006
Specialty
Internal Medicine
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1200 Brooks Ln, Suite G10
Clairton, PA, 15025
Phone (724) 469-5914
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
1,075 services
Medicare patients, 2024
542
Average age 72
Drug cost, 2024
$1.5M
4,678 prescriptions
Company payments, 2025
$1,036
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alfonso Barbati was code 99213 (office e&m - established), 266 times for 131 patients. In total Alfonso Barbati billed 1,075 services in 31 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 266 | 131 | $49.72 | $13K |
| 43239 Upper GI Endoscopy | Facility | 166 | 161 | $77.40 | $13K |
| 45380 Lower GI Endoscopy - Other | Facility | 151 | 151 | $119.95 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 112 | 61 | $58.53 | $6,555 |
| 99222 Hospital E&M - Initial | Facility | 97 | 94 | $94.46 | $9,162 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 73 | 73 | $173.20 | $13K |
| 45385 Colonoscopy - Lesion Removal | Facility | 69 | 69 | $199.20 | $14K |
| 99221 Hospital E&M - Initial | Facility | 22 | 21 | $54.86 | $1,207 |
| 43235 Upper GI Endoscopy | Facility | 21 | 20 | $70.72 | $1,485 |
| 99203 Office E&M - New | Office | 17 | 17 | $79.65 | $1,354 |
| 43450 Digestive/Gastrointestinal | Facility | 14 | 13 | $28.17 | $394 |
By year: 2022 $104K for 1,071 services; 2023 $97K for 996 services; 2024 $102K for 1,075 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alfonso Barbati prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,286 prescriptions and refills. In total Alfonso Barbati wrote 4,678 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,286 | 2,412 | 350 | $10K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 679 | 684 | 668 | $48K |
| Famotidine Generic | 482 | 888 | 126 | $3,702 |
| Omeprazole Generic | 179 | 401 | 45 | $1,491 |
| Linzess Linaclotide | 178 | 236 | 50 | $122K |
| Colestipol Hcl Generic | 151 | 243 | 53 | $12K |
| Mesalamine Generic | 146 | 252 | 25 | $97K |
| Dicyclomine Hcl Generic | 137 | 227 | 38 | $3,853 |
| Esomeprazole Magnesium Generic | 95 | 199 | 22 | $2,529 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 93 | 93 | 93 | $15K |
| Mesalamine Er Mesalamine | 89 | 189 | 21 | $61K |
| Budesonide Dr Budesonide | 82 | 126 | 22 | $20K |
| Sucralfate Generic | 78 | 110 | 23 | $10K |
| Glycopyrrolate Generic | 61 | 145 | 22 | $2,916 |
| Dexlansoprazole Dr Dexlansoprazole | 59 | 137 | 15 | $33K |
Brand drugs: 837 claims; generic drugs: 3,841 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alfonso Barbati $1,036 ($1,036 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $312.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $312 |
| Madrigal Pharmaceuticals MDGL | 13 | $241 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $112 |
| Janssen Biotech, Inc. JNJ | 3 | $71.15 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $68.66 |
| Novo Nordisk Inc NVO | 2 | $67.68 |
| Pfizer Inc. PFE | 3 | $58.89 |
| Ardelyx, Inc. ARDX | 2 | $43.38 |
| Intercept Pharmaceuticals, Inc. | 1 | $26.57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $19.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.